| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Gynecology and Obstetrics (Y.R.S., M.G.d.C., H.A.Z.) and Department of Radiology, Division of Nuclear Medicine (J.-K.Z., R.F.D., H.T.R., J.J.F.), The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287
Address all correspondence and requests for reprints to: J. James Frost, M.D., Ph.D., Department of Radiology, Division of Nuclear Medicine, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Nelson B1130, Baltimore, Maryland 21287. E-mail: jfrost{at}receptor.rad.jhu.edu
The regulation of central µ-opioid receptors in women during the menstrual cycle was explored with positron emission tomography and the selective radiotracer [11C]carfentanil. Ten healthy women were studied twice, during their follicular and luteal phases. Plasma concentrations of estradiol, progesterone, testosterone, and ß-endorphin were determined immediately before scanning. LH pulsatility was measured over the 9 h preceding each of the two positron emission tomography scans. No significant differences in the binding potential of µ-opioid receptors (binding capacity/Kd) were observed between phases of the menstrual cycle. However, significant negative correlations were observed between circulating levels of estradiol during the follicular phase and µ-receptor binding measures in the amygdala and hypothalamus, two regions thought to be involved in the regulation of GnRH pulsatility. LH pulse amplitude was positively correlated with µ binding in the amygdala, whereas LH pulse number was negatively correlated with binding in this same region. No significant associations were noted between LH pulse measures and the hypothalamus for this sample. These results suggest that amygdalar µ-opioid receptors exert a modulatory effect on GnRH pulsatility, and that circulating levels of estradiol also regulate central µ-opioid function.
This article has been cited by other articles:
![]() |
G. Henriksen and F. Willoch Imaging of opioid receptors in the central nervous system Brain, May 1, 2008; 131(5): 1171 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kennedy, R. A. Koeppe, E. A. Young, and J.-K. Zubieta Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry, November 1, 2006; 63(11): 1199 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Smith, C. S. Stohler, T. E. Nichols, J. A. Bueller, R. A. Koeppe, and J.-K. Zubieta Pronociceptive and Antinociceptive Effects of Estradiol through Endogenous Opioid Neurotransmission in Women J. Neurosci., May 24, 2006; 26(21): 5777 - 5785. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Benedetti, H. S. Mayberg, T. D. Wager, C. S. Stohler, and J.-K. Zubieta Neurobiological Mechanisms of the Placebo Effect J. Neurosci., November 9, 2005; 25(45): 10390 - 10402. [Full Text] [PDF] |
||||
![]() |
J.-K. Zubieta, J. A. Bueller, L. R. Jackson, D. J. Scott, Y. Xu, R. A. Koeppe, T. E. Nichols, and C. S. Stohler Placebo Effects Mediated by Endogenous Opioid Activity on {micro}-Opioid Receptors J. Neurosci., August 24, 2005; 25(34): 7754 - 7762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Zubieta, T. A. Ketter, J. A. Bueller, Y. Xu, M. R. Kilbourn, E. A. Young, and R. A. Koeppe Regulation of Human Affective Responses by Anterior Cingulate and Limbic {micro}-Opioid Neurotransmission Arch Gen Psychiatry, November 1, 2003; 60(11): 1145 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Zubieta, Y. R. Smith, J. A. Bueller, Y. Xu, M. R. Kilbourn, D. M. Jewett, C. R. Meyer, R. A. Koeppe, and C. S. Stohler {micro}-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women J. Neurosci., June 15, 2002; 22(12): 5100 - 5107. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |